Insightec, a pioneer in focused ultrasound technology for transforming patient care, has successfully raised $150 million in its Series G equity financing round.
With over 160 systems installed worldwide and 20,000 commercial applications, Insightec’s groundbreaking technology is redefining treatment for essential tremor and Parkinson’s disease. This substantial funding will enable Insightec to further enhance its innovative solutions, expand its global reach, and continue to revolutionize patient care.
Insightec’s focused ultrasound technology represents a significant advancement in medical treatment, offering non-invasive alternatives to traditional surgeries and improving the quality of life for patients. We are incredibly proud to support Insightec in its mission to make a lasting impact on global health and look forward to their next steps in this transformative journey.
